Arguing proposed funding should remain flexible . . .

Dems Reject GOP Bid To Target Where FDA Spends COVID-19 Funds

By Beth Wang / February 11, 2021 at 7:41 PM
House Energy & Commerce Committee Democrats struck down Republicans’ attempt to direct FDA to use $100 million, of the $500 million allocated to the agency in E&C’s COVID-19 relief proposal, to review novel and repurposed therapies for COVID-19. Democrats agreed FDA should work to get more COVID-19 therapies to market, but they argued the agency needs flexibility to use funding where it’s needed most. E&C Democrats’ pandemic relief legislation, unveiled Feb. 9, would give FDA $500 million to continuously evaluate...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.